Top 10 Tech Stocks To Buy For 2018

Related NUAN Watch These 8 Huge Put Purchases In Wednesday Trade Benzinga's Option Alert Recap From May 9
Related NBR Mid-Afternoon Market Update: LeMaitre Vascular Rises After Strong Q1 Results; Synchronoss Technologies Shares Plunge 20 Biggest Mid-Day Losers For Thursday

On CNBC's Fast Money Halftime Report, Jon Najarian spoke about high options activity in Nuance Communications Inc. (NASDAQ: NUAN). Traders were buying the June 19 calls for $1. The trade breaks even at $20 or 2.20 percent above the closing price on Wednesday. Najarian followed the trade and he is going to hold the position for two weeks.

Pete Najarian was watching Nabors Industries Ltd. (NYSE: NBR). He said that the stock has been trading in a range between $8 and $18 over the last 52 weeks and although it spiked 2.82 percent on Wednesday, it's still close to the lower end of the range. Anticipating a move higher, traders were buying the June 11 calls for $0.30. Around 6,000 contracts were bought in the first half of the session. The trade breaks even at $11.30 or 10.78 percent above the current market price. Pete Najarian decided to buy the calls and he is going to hold them for 4-5 weeks.

Top 10 Tech Stocks To Buy For 2018: Cognizant Technology Solutions Corporation(CTSH)

Advisors’ Opinion:

  • [By Monica Gerson]

    Cognizant Technology Solutions Corp (NASDAQ: CTSH) is estimated to report its quarterly earnings at $0.79 per share on revenue of $3.23 billion.

    CIGNA Corporation (NYSE: CI) is projected to report its quarterly earnings at $2.15 per share on revenue of $10.00 billion.

  • [By Paul Ausick]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) dropped more than 17% on Friday to post a new 52-week low of $45.44 after closing at $55.00 on Thursday. The stock’s 52-week high is $69.80. Volume was more than 10 times the daily average of around 4.2 million shares. The company’s president has been replaced as an investigation into possible corruption charges begins.

  • [By Lee Jackson]

    Cognizant Technology Solutions Corp. (NASDAQ: CTSH) is starting to show up as a stock to buy for many of the Wall Street firms we cover. The company was very bullish at the conference and cited a very solid demand environment that is expected to continue through next year. The Deutsche Bank target for the stock is placed at $92, while the consensus number is at $87.

Top 10 Tech Stocks To Buy For 2018: Finisar Corporation(FNSR)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By Lisa Levin]

    Shares of Foresight Autonomous Holdings ADR (NASDAQ: FNSR) were down 8 percent to $4.34. On Friday, Foresight posted Q3 non-GAAP net loss of $2,086,000, versus a year-ago non-GAAP net loss of $879,000.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Finisar Corporation (NASDAQ: FNSR) reported in-line earnings for its fourth quarter, but issued a weak forecast for the current quarter. Finisar shares jumped 7.76 percent to $27.63 in the after-hours trading session.
    Shares of Booz Allen Hamilton Holding Corporation (NYSE: BAH) dropped over 13 percent in after-hours trading as the company reported a DoJ civil and criminal investigation regarding cost accounting and cost charging practices. Booz Allen shares dipped 13.30 percent to $34.10 in the after-hours trading session.
    Bob Evans Farms Inc (NASDAQ: BOBE) shares declined over 4 percent Thursday after the company reported results for its fourth quarter. The company posted better-than-expected Q4 earnings, while sales missed estimates. Bob Evans shares dropped 4.26 percent to close at $68.99 on Thursday.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Leo Sun]

    Shares of fiber optic components maker Finisar (NASDAQ:FNSR) fell 17% in April due to a big third-quarter miss in mid-March. Its revenue rose 23% annually to $380.6 million, but that missed expectations by $9 million. Earnings rose136% to $0.59 per share, but that also missed estimates by three cents. Finisar’s top and bottom line guidance for the fourth quarter (16% sales growth and 83% earnings growth at the midpoints) also came in below Wall Street estimates.

  • [By Paul Ausick]

    Finisar Corp. (NASDAQ: FNSR) posted a new 52-week low of $17.81 Monday, down about 7.5% after closing at $19.26 on Friday. The 52-week high is $36.85. Volume was about 6.4 million, nearly double the daily average of around 3.4 million shares. The optical technology company had no specific news.

Top 10 Tech Stocks To Buy For 2018: Autohome Inc.(ATHM)

Advisors’ Opinion:

  • [By Monica Gerson]

    Autohome Inc (ADR) (NYSE: ATHM) is estimated to report its quarterly earnings at $1.68 per share on revenue of $1.05 billion.

    Vera Bradley, Inc. (NASDAQ: VRA) is expected to report its quarterly earnings at $0.05 per share on revenue of $106.75 million.

  • [By R. Chandrasekaran]

    The following stocks are rated with Neutral:

    JD.Com Inc(ADR) (NASDAQ: JD). Vipshop Holdings Ltd – ADR (NYSE: VIPS). Autohome Inc (ADR) (NYSE: ATHM). SouFun Holdings Ltd (NYSE: SFUN). Leju Holdings Ltd (ADR) (NYSE: LEJU).
    Underweight Names

    The following stocks are rated Underweight:

Top 10 Tech Stocks To Buy For 2018: Fitbit, Inc.(FIT)

Advisors’ Opinion:

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

  • [By Paul Ausick]

    Fitbit Inc. (NYSE: FIT) dropped about 1.9% on Wednesday to post a new 52-week low of $7.30 after closing at $7.44 on Tuesday. The stock’s 52-week high is $30.96. Volume was about 10% below the daily average of around 10 million shares. Analysts at Pacific Crest said that the company’s inventory continues increasing and lowered the firm’s expectations for unit sales in the first fiscal quarter of 2017.

  • [By Peter Graham]

    Small cap Fitbit Inc (NYSE: FIT), which designs products that track everyday health and fitness,is probably the most well know pure play wearables focused stock to investorsin part because is started off as a high flying pioneer in the space and shares had taken off after its 2015 IPO. However, thatshare performance has not lived up to the lofty investor expectations expected of a stock that became synonymous with wearables:

  • [By Todd Campbell]

    Leveraging data to transform healthcare is only in its infancy, but we’re already seeing examples of how wearable technology may help patients. For example, Fitbit(NYSE:FIT)and Apple(NASDAQ:AAPL)sell consumer-electronics devices that measure and report health information, such as activity levels and heart rate, so that people cantrack the progress they’re making toward their health goals, such as weight loss. Soon, data that these wearable devices collect could become even more useful as more sophisticated sensors are incorporated into them.

  • [By Ashley Moore]

    We saw it with GoPro Inc. (Nasdaq: GPRO) and Fitbit Inc. (NYSE: FIT). Both are trading about 90% below their post-IPO peak prices.

    “The thought that any sane investor would buy Snapchat is frightening,” said Money Morning Capital Wave Strategist Shah Gilani. “Buying shares in SNAP is like trying to pick up nickels in front of buses.”

Top 10 Tech Stocks To Buy For 2018: EPAM Systems, Inc.(EPAM)

Advisors’ Opinion:

  • [By Anders Bylund, Chuck Saletta, and Brian Feroldi]

    Read on to see why they pickedAllstate(NYSE:ALL),EPAM Systems(NYSE:EPAM), andUniversal Display(NASDAQ:OLED).

    Image source: Getty Images.

Top 10 Tech Stocks To Buy For 2018: Axcelis Technologies Inc.(ACLS)

Advisors’ Opinion:

  • [By Chris Dier-Scalise]

    "We have three stocks that we have identified, Excelis Technologies Inc (NASDAQ: ACLS), Cohu, Inc. (NASDAQ: COHU), and Entegris Inc (NASDAQ: ENTG). All of these companies spiked up on their recent positive earnings surprises and they’ve now pulled back to the point that we think they‘re attractive"

  • [By Anders Bylund]

    Shares of Axcelis Technologies (NASDAQ:ACLS) gained 21.7% in March 2017, according to data from S&P Global Market Intelligence.

    So what

    The maker of manufacturing equipment for semiconductor factories is largely following the medium-term trajectory of the industry-tracking PHLX Semiconductor index. Being a small-cap player in that large sector, Axcelis saw its share prices falling in early March only to whipsaw back to a strong gain on heavy trading volume.

Top 10 Tech Stocks To Buy For 2018: Molex Incorporated(MOLX)

Advisors’ Opinion:

  • [By Shauna O’Brien]

    Shares of electronic connector maker Molex Incorporated (MOLX) skyrocketed on Monday morning after reports that the company will be acquired by Koch Industries.

    Koch Industries has agreed to acquire Molex for a total of $7.2 billion. This deal will include all outstanding shares of the company’s Common Stock, Class A Common Stock and Class B Common Stock for $38.50 per share.

    The deal has been approved by the board of directors of both companies. Molex will continue to maintain its current management team and its current headquarters in Lisle, IL.

    Molex shares were up $9.15, or 31.17%, during Monday morning trading. The stock is up 41% YTD.

Top 10 Tech Stocks To Buy For 2018: Rackspace Hosting Inc(RAX)

Advisors’ Opinion:

  • [By Monica Gerson]

    Rackspace Hosting, Inc. (NYSE: RAX) reported better-than-expected earnings for the first quarter, but the company missed analysts’ sales estimates. Rackspace shares dropped 7.72 percent to $20.80 in the after-hours trading session.

Top 10 Tech Stocks To Buy For 2018: Netlist, Inc.(NLST)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Friday, our Elite Opportunity Pronewsletter suggested small cap data/memory solutions stocksNetlist, Inc (NASDAQ: NLST) as a long/bullish position for our short term portfolio:

Top 10 Tech Stocks To Buy For 2018: Novellus Systems Inc.(NVLS)

Advisors’ Opinion:

  • [By Paul Ausick]

    Nivalis Therapeutics Inc. (NASDAQ: NVLS) dropped 60% on Tuesday to post a new 52-week low of $2.50 after closing at $6.25 on Monday. The stock’s 52-week high is $9.45. Volume of about 4.2million was about 60 times the daily average of around 75,000 shares. The company reported a failed mid-stage trial on its treatment for cystic fibrosis.

  • [By Chris Lange]

    Nivalis Therapeutics, Inc. (NASDAQ: NVLS) is watching its shares crumble on Tuesday after the company gave an update on its mid-stage Cystic Fibrosis (CF) trial. Specifically, the company announced topline results from the its Phase 2 trial evaluating the efficacy and safety of two doses of cavosonstat, in adult patients with CF who had two copies of the F508del-CFTR mutation and were being treated with Orkambi.

  • [By Lisa Levin]

    Nivalis Therapeutics Inc (NASDAQ: NVLS) shares dropped 59 percent to $2.58 after the company reported it failed to demonstrate benefit in absolute change in predicted FEV1 or in Sweat Chloride Reduction at 12 weeks. The failed trial has prompted four Wall Street firms to downgrade the issue including Raymond James, Cowen, Baird and Stifel.

Leave a Reply

Your email address will not be published. Required fields are marked *